One of the trusted digital health platforms, BrightInsight, has announced today about the launch of its Disease Management Solution, at BIO 2022. Analytics Dashboards, Patients App and Healthcare Provider interfaces are included in this Configurable suite of digital applications.
Kal Patel, M.D, CEO and Co-Founder of BrightInsight said that they have developed the Disease Management Solution to enable biopharma and medtech to accelerate time to market for SaMD and regulated digital solutions. With this launch, biopharma and medtech companies can construct their adaptable, comprehensive solution to improve distinctive and highly differentiated digital offerings to transform how patients manage their conditions.
He further said that with the Disease Management Solution, their clients can harness real-world data to demonstrate treatment value, differentiate their therapies and ultimately increase revenue.
